General Information of the Compound
Compound ID
CP0208525
Compound Name
N-[4-(6-bromo-2,3-dihydroindol-1-yl)quinazolin-6-yl]prop-2-enamide
    Show/Hide
Structure
Formula
C19H15BrN4O
Molecular Weight
395.26
Canonical SMILES
Brc1ccc2CCN(c2c1)c1ncnc2ccc(NC(=O)C=C)cc12
    Show/Hide
InChI
InChI=1S/C19H15BrN4O/c1-2-18(25)23-14-5-6-16-15(10-14)19(22-11-21-16)24-8-7-12-3-4-13(20)9-17(12)24/h2-6,9-11H,1,7-8H2,(H,23,25)
    Show/Hide
InChIKey
NIPWAVUDLFTENM-UHFFFAOYSA-N
Physicochemical Property
logP
4.211
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
58.12
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9908666
SID: 14878806
ChEMBL ID
CHEMBL51741
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 9.9 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM